Bank Hapoalim Bm:企業の戦略・SWOT・財務分析

◆英語タイトル:Bank Hapoalim Bm - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3392
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Bank Hapoalim Bm – Strategy, SWOT and Corporate Finance Report
Summary

Bank Hapoalim Bm – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bank Hapoalim BM (Bank Hapoalim) offers a range of retail, commercial, corporate, and private banking and other financial solutions. Its product portfolio includes loans for mortgages, real estate, working capital, and lines of credit; asset based loans; letters of credit; time deposits; loan sweep accounts; zero balance accounts; foreign currency drafts; and credit and debit cards. The bank also offers services such as cash management, foreign securities, trust, asset management, money transfers, treasury, and foreign exchange, among others. The bank operates through branches, representative offices, and subsidiaries in North America and Europe. Bank Hapoalim is headquartered in Tel-Aviv, Israel.

Scope

- Detailed information on Bank Hapoalim Bm required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bank Hapoalim Bm in the form of a SWOT analysis
- An in-depth view of the business model of Bank Hapoalim Bm including a breakdown and examination of key business segments
- Intelligence on Bank Hapoalim Bm’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bank Hapoalim Bm, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bank Hapoalim Bm and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bank Hapoalim Bm as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bank Hapoalim Bm’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Bank Hapoalim BM: Company Overview
Bank Hapoalim BM: Overview and Key Facts
Bank Hapoalim BM: Overview
Bank Hapoalim BM: Key Facts
Bank Hapoalim BM: Key Employees
Bank Hapoalim BM: Key Employee Biographies
Bank Hapoalim BM: Major Products and Services
Bank Hapoalim BM: Company History
Bank Hapoalim BM: Management Statement
Bank Hapoalim BM: Locations and Subsidiaries
Bank Hapoalim BM: Key Competitors
Bank Hapoalim BM: Company Analysis
Bank Hapoalim BM: Business Description
Bank Hapoalim BM: SWOT Analysis
Bank Hapoalim BM: SWOT Overview
Bank Hapoalim BM: Strengths
Bank Hapoalim BM: Weaknesses
Bank Hapoalim BM: Opportunities
Bank Hapoalim BM: Threats
Bank Hapoalim BM: Corporate Financial Deals Activity
Bank Hapoalim BM: Financial Deals Overview
Bank Hapoalim BM: Targets and Partners
Bank Hapoalim BM: Top Deals 2015 – 2019YTD*
Bank Hapoalim BM: Corporate Venturing
Bank Hapoalim BM: Capital Raising
Bank Hapoalim BM: Divestments
Bank Hapoalim BM: Private Equity and Ownership
Bank Hapoalim BM: Recent Developments
Bank Hapoalim BM: News and Events Summary
Bank Hapoalim BM: Business Reorganization
Bank Hapoalim BM: Contracts
Bank Hapoalim BM: Corporate Governance
Bank Hapoalim BM: Financial Deals
Bank Hapoalim BM: Financial Performance
Bank Hapoalim BM: Regulatory and Legal Events
Bank Hapoalim BM: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Bank Hapoalim BM: Key Facts
Table 2: Bank Hapoalim BM: Key Employees
Table 3: Bank Hapoalim BM: Company History
Table 4: Bank Hapoalim BM: Locations and Subsidiaries
Table 5: Bank Hapoalim BM: Key Competitors
Table 6: Bank Hapoalim BM: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Bank Hapoalim BM: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Bank Hapoalim BM: Targets and Partners
Table 9: Bank Hapoalim BM: Top Deals 2015 - 2019YTD*
Table 10: Bank Hapoalim BM: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 11: Bank Hapoalim BM: Corporate Venturing by Geography (2015 - YTD*2019)
Table 12: Bank Hapoalim BM: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 13: Bank Hapoalim BM: Capital Raising by Deal Type (2015 - YTD*2019)
Table 14: Bank Hapoalim BM: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 15: Bank Hapoalim BM: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Table 16: Bank Hapoalim BM: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)
Table 17: Bank Hapoalim BM: News and Events Summary
Table 18: Bank Hapoalim BM: Business Reorganization
Table 19: Bank Hapoalim BM: Contracts
Table 20: Bank Hapoalim BM: Corporate Governance
Table 21: Bank Hapoalim BM: Financial Deals
Table 22: Bank Hapoalim BM: Financial Performance
Table 23: Bank Hapoalim BM: Regulatory and Legal Events
Table 24: Bank Hapoalim BM: Strategy and Operations

★海外企業調査レポート[Bank Hapoalim Bm:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Thornton & Ross Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products compris …
  • Aequus Pharmaceuticals Inc (AQS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …
  • Veritas Genetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Veritas Genetics Inc (Veritas Genetics) is a genome sequencing company that offers genomics testing and sequencing products and services. The company delivers actionable genetic insights to individuals and their doctors based on their DNA to manage their disease risk and plan their family he …
  • Consumers Energy Co (CMS PR B):企業の財務・戦略的SWOT分析
    Consumers Energy Co (CMS PR B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Leidos Holdings Inc:企業のM&A・事業提携・投資動向
    Leidos Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leidos Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Vergnet SA (ALVER):企業の財務・戦略的SWOT分析
    Vergnet SA (ALVER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Medigus Ltd (MDGS)-医療機器分野:企業M&A・提携分析
    Summary Medigus Ltd (Medigus) is a medical equipment provider that offers endoscopic procedures and devices. The company’s muse system enables endoscopists to treat gastroesophageal reflux disease by performing fundoplication procedures through the mouth. It offers various rigid, semi-flexible and f …
  • Aspen Insurance Holdings Limited:戦略・SWOT・企業財務分析
    Aspen Insurance Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Aspen Insurance Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CytImmune Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CytImmune Sciences Inc (CytImmune) is a clinical stage nanomedicine company that discovers, develops, and commercializes tumor-targeted therapies. The company develops nanotherapy platform, Aurimune, a tumor-targeted trojan horse. Its Aurimune binds TNF receptors on blood vessel cells at the …
  • Lennox International Inc (LII):企業の財務・戦略的SWOT分析
    Lennox International Inc (LII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Robinson Helicopter Company, Inc.:企業の戦略・SWOT・財務分析
    Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Kura Oncology Inc (KURA)-製薬・医療分野:企業M&A・提携分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company which discovers and develops therapeutics for the treatment of solid tumors and blood cancers. Its lead drug candidate, Tipifarnib, an inhibitor of protein farnesylation, is a small molecule that targets oncogene …
  • Teladoc Health Inc (TDOC):企業の財務・戦略的SWOT分析
    Summary Teladoc Health Inc (Teladoc Health), formerly TelaDoc Inc, is a provider of virtual healthcare services for wellness and prevention of acute care and complex healthcare needs. It offers primary care services managing chronic conditions; mental health guidance; personalized digital healthcare …
  • Halliburton Co (HAL):企業の財務・戦略的SWOT分析
    Halliburton Co (HAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mediobanca Private Banking:企業の戦略・SWOT・財務情報
    Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report Summary Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Continental Grain Company
    Continental Grain Company - Strategy, SWOT and Corporate Finance Report Summary Continental Grain Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Neusoft Corporation (600718):企業の財務・戦略的SWOT分析
    Neusoft Corporation (600718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Blackthorn Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Blackthorn Therapeutics Inc (Blackthorn Therapeutics) is a clinical stage biopharmaceutical company that discovers and develops targeted treatments for neurobehavioral disorders. The company offers products such as BTRX-246040, an NOPR antagonist; and BTRX-335140, a KOR antagonist. It uses I …
  • De La Rue Plc (DLAR):企業の財務・戦略的SWOT分析
    De La Rue Plc (DLAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆